Ketamine interactions with biomarkers of stress: A randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men

NeuroImage

Volumn 108, Issue , 2015, Pages 396-409

  Khalili Mahani, Najmeh ^a,b,f   Niesters, Marieke ^a   van Osch, Matthias J ^a,b   Oitzl, Melly ^c   Veer, Ilya ^a,b,d   de Rooij, Mark ^b   van Gerven, Joop ^a   van Buchem, Mark A ^a   Beckmann, Christian F ^e   Rombouts, Serge A R B ^a,b   Dahan, Albert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYDROCORTISONE; KETAMINE; PLACEBO; SPIN LABELING;

ADULT; ALERTNESS; ARTICLE; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN PERFUSION; CEREBELLUM; CHEMICAL LABELING; CINGULATE GYRUS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSE COMPARISON; DRUG INFUSION; DRUG MECHANISM; DRUG MEGADOSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; MEMORY DISORDER; NEGATIVE FEEDBACK; NERVE CELL NETWORK; NEUROTRANSMISSION; NORMAL HUMAN; OCCIPITAL CORTEX; PILOT STUDY; PRECUNEUS; PREFRONTAL CORTEX; PSEUDOCONTINUOUS ARTERIAL SPIN LABELING; RANDOMIZED CONTROLLED TRIAL; RESTING STATE FUNCTIONAL MAGNETIC RESONANCE IMAGING; SALIVA LEVEL; STRESS; WORKING MEMORY; BRAIN; CHEMISTRY; DRUG EFFECTS; MENTAL STRESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; REST; SALIVA; SINGLE BLIND PROCEDURE; SPIN LABELING; YOUNG ADULT;

ADULT; BIOMARKERS; BRAIN; CROSS-OVER STUDIES; HIPPOCAMPUS; HUMANS; HYDROCORTISONE; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; PILOT PROJECTS; REST; SALIVA; SINGLE-BLIND METHOD; SPIN LABELS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84922265531     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.12.050     Document Type: Article

References (104)

1. Anticevic A., et al. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(41):16720-16725.
2. Armanini M.P., et al. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res. 1990, 532(1-2):7-12.
3. Becerra L., Schwartzman R.J., Kiefer R.T., Rohr P., Moulton E.A., Wallin D., Pendse G., Morris S., Borsook D. CNS Measures of Pain Responses Pre- and Post-Anesthetic Ketamine in a Patient with Complex Regional Pain Syndrome 2009, Pain Medicine. 10.1111/j.1526-4637.2009.00559.x.
4. Benarroch E.E. NMDA receptors: recent insights and clinical correlations. Neurology 2011, 76(20):1750-1757.
5. Birn R.M. The role of physiological noise in resting-state functional connectivity. NeuroImage 2012, 62(2):864-870.
6. Bond A., Lader M. Use of analog scales in rating subjective feelings. Br. J. Med. Psychol. 1974, 47:211-218.
7. Breier A., et al. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry 1997, 154(6):805-811.
8. Bekkers J.M., Stevens C.F. NMDA and non-NMDA receptors are co-localized at individual excitatory synapses in cultured rat hippocampus. Nature 1989, 341(6239):230-233.
9. Brookes M.J., et al. Measuring functional connectivity using MEG: methodology and comparison with fcMRI. NeuroImage 2011, 56(3):1082-1104.
10. Burke H.M., et al. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 2005, 30(9):846-856.
11. Burnham K.P., Anderson D.R. Model Selection and Multimodel Inference: A Practical Information-theoretic Approach 2002, Springer-Verlag. 2 edn.
12. Carlson P.J., et al. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study. Biol. Psychiatry 2013, 73(12):1213-1221.
13. Chambers R.A., et al. Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Semin. Clin. Neuropsychiatry 1999, 4(4):274-281.
14. Chaouloff F., Hemar A., Manzoni O. Acute stress facilitates hippocampal CA1 metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 2007, 27(27):7130-7135.
15. Dahan A., et al. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur. J. Pain 2011, 15(3):258-267.
16. De Kloet E.R., et al. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19(3):269-301.
17. de Kloet E.R., Karst H., Joels M. Corticosteroid hormones in the central stress response: quick-and-slow. Front. Neuroendocrinol. 2008, 29(2):268-272.
18. de Leon M.J., et al. Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet 1988, 2(8607):391-392.
19. de Quervain D.J., et al. Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur. J. Neurosci. 2003, 17(6):1296-1302.
20. De Simoni S., et al. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers. NeuroImage 2013, 64:75-90.
21. Deakin J.F., et al. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch. Gen. Psychiatry 2008, 65(2):154-164.
22. Diamond P.R., et al. Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic. J. Psychopharmacol. 2014, 28(6):536-544.
23. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 2004, 130(3):355-391.
24. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 1993, 13(9):3839-3847.
25. Doyle O.M., et al. Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents. J. Pharmacol. Exp. Ther. 2013, 345(1):151-160.
26. Driesen N.R., et al. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol. Psychiatry 2013, 18:1199-1204.
27. Feder A., et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 2014, 71(6):681-688.
28. Galvez V., et al. Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report. Biol. Psychiatry 2014, 76(3):e1-e2.
29. Groeneweg F.L., et al. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J. Endocrinol. 2011, 209(2):153-167.
30. Harrison P.J., Law A.J., Eastwood S.L. Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann. N. Y. Acad. Sci. 2003, 1003:94-101.
31. Hellhammer D.H., Wust S., Kudielka B.M. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 2009, 34(2):163-171.
32. Hergovich N., et al. Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men. a randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology 2001, 24(5):590-593.
33. Herman J.P., Mueller N.K. Role of the ventral subiculum in stress integration. Behav. Brain Res. 2006, 174(2):215-224.
34. Herman J.P., et al. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(8):1201-1213.
35. Hocking G., Cousins M.J. Ketamine in chronic pain management: an evidence-based review. Anesth. Analg. 2003, 97(6):1730-1739.
36. Holcomb H.H., et al. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology 2005, 30(12):2275-2282.
37. Jahn A.L., et al. Subgenual prefrontal cortex activity predicts individual differences in hypothalamic-pituitary-adrenal activity across different contexts. Biol. Psychiatry 2010, 67(2):175-181.
38. Khalili-Mahani N., et al. Hippocampal activation during a cognitive task is associated with subsequent neuroendocrine and cognitive responses to psychological stress. Hippocampus 2010, 20(2):323-334.
39. Khalili-Mahani N., et al. Spatial heterogeneity of the relation between resting-state connectivity and blood flow: an important consideration for pharmacological studies. Hum. Brain Mapp. 2014, 35(3):929-942.
40. Khalili-Mahani N., et al. The impact of "physiological correction" on functional connectivity analysis of pharmacological resting state fMRI. NeuroImage 2013, 65:499-510.
41. Kiem S.A., et al. Resting state functional MRI connectivity predicts hypothalamus-pituitary-axis status in healthy males. Psychoneuroendocrinology 2013, 38(8):1338-1348.
42. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 1989, 22(3):150-169.
43. Krystal J.H., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 1994, 51(3):199-214.
44. Lahti A.C., et al. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Res. 2005, 139(1):19-30.
45. Liu X., Li S.J., Hudetz A.G. Increased precuneus connectivity during propofol sedation. Neurosci. Lett. 2014, 561:18-23.
46. Lord C., et al. Stress response in postpartum women with and without obsessive-compulsive symptoms: an fMRI study. J. Psychiatry Neurosci. 2012, 37(2):78-86.
47. Lovallo W.R., et al. Acute effects of hydrocortisone on the human brain: an fMRI study. Psychoneuroendocrinology 2010, 35(1):15-20.
48. Lupien S.J., et al. The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition. Brain Cogn. 2007, 65(3):209-237.
49. Lupien S.J., et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 2009, 10(6):434-445.
50. Maggio N., Segal M. Striking variations in corticosteroid modulation of long-term potentiation along the septotemporal axis of the hippocampus. J. Neurosci. 2007, 27(21):5757-5765.
51. Malykhin N.V., et al. Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J. Psychiatry Neurosci. 2010, 35(5):337-343.
52. Martin K.P., Wellman C.L. NMDA receptor blockade alters stress-induced dendritic remodeling in medial prefrontal cortex. Cereb. Cortex 2011, 21(10):2366-2373.
53. Martin S., et al. Corticosterone alters AMPAR mobility and facilitates bidirectional synaptic plasticity. PLoS One 2009, 4(3):e4714.
54. Maruszak A., Thuret S. Why looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis. Front. Cell. Neurosci. 2014, 8:95.
55. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 1999, 22:105-122.
56. McEwen B.S. Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin. Neurosci. 2006, 8(4):367-381.
57. McEwen B.S., Morrison J.H. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 2013, 79(1):16-29.
58. McEwen B.S., Weiss J.M., Schwartz L.S. Selective retention of corticosterone by limbic structures in rat brain. Nature 1968, 220(5170):911-912.
59. McNaughton N. The role of the subiculum within the behavioural inhibition system. Behav. Brain Res. 2006, 174(2):232-250.
60. Meaney M.J., Szyf M., Seckl J.R. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol. Med. 2007, 13(7):269-277.
61. Moghaddam B., et al. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 1997, 17(8):2921-2927.
62. Murrough J.W., et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am. J. Psychiatry 2013, 170(10):1134-1142.
63. Musso F., et al. Ketamine effects on brain function-simultaneous fMRI/EEG during a visual oddball task. NeuroImage 2011, 58(2):508-525.
64. Nagels A., et al. Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency. Eur. Arch. Psychiatry Clin. Neurosci. 2012, 262(5):403-414.
65. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15(1):1-25.
66. Niciu M.J., et al. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. Annu. Rev. Pharmacol. Toxicol. 2014, 54:119-139.
67. Niesters M., et al. Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers. Anesthesiology 2012, 117(4):868-877.
68. Niesters M., et al. Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study. Br. J. Anaesth. 2013, 110(6):1010-1016.
69. Northoff G., et al. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI. Schizophr. Res. 2005, 72(2-3):235-248.
70. Oei N.Y., et al. Glucocorticoids decrease hippocampal and prefrontal activation during declarative memory retrieval in young men. Brain Imaging Behav. 2007, 1(1-2):31-41.
71. Oitzl M.S., et al. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci. Biobehav. Rev. 2010, 34(6):853-866.
72. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 1995, 52(12):998-1007.
73. Packan D.R., Sapolsky R.M. Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity. Neuroendocrinology 1990, 51(6):613-618.
74. Peeters F., Nicholson N.A., Berkhof J. Cortisol responses to daily events in major depressive disorder. Psychosom. Med. 2003, 65(5):836-841.
75. Popoli M., et al. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat. Rev. Neurosci. 2012, 13(1):22-37.
76. Poppenk J., et al. Long-axis specialization of the human hippocampus. Trends Cogn. Sci. 2013, 17(5):230-240.
77. Pruessner J.C., et al. Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies. Biol. Psychiatry 2008, 63(2):234-240.
78. Radley J.J., Sawchenko P.E. A common substrate for prefrontal and hippocampal inhibition of the neuroendocrine stress response. J. Neurosci. 2011, 31(26):9683-9695.
79. Rigby M., et al. The messenger RNAs for the N-methyl-d-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience 1996, 73(2):429-447.
80. Rogers R., et al. An investigation to dissociate the analgesic and anesthetic properties of ketamine using functional magnetic resonance imaging. Anesthesiology 2004, 100(2):292-301.
81. Rowland D.C., Kentros C.G. Potential anatomical basis for attentional modulation of hippocampal neurons. Ann. N. Y. Acad. Sci. 2008, 1129:213-224.
82. Scheidegger M., et al. Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. PLoS One 2012, 7(9):e44799.
83. Selye H. The general-adaptation-syndrome. Annu. Rev. Med. 1951, 2:327-342.
84. Sigtermans M., et al. An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients. Eur. J. Pain 2010, 14(3):302-307.
85. Small S.A., et al. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 2011, 12(10):585-601.
86. Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009, 44(1):83-98.
87. Stern C.E., et al. The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(16):8660-8665.
88. Symonds C.S., et al. Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRI. Eur. Neuropsychopharmacol. 2012, 22(12):867-874.
89. Thomason M.E., Hamilton J.P., Gotlib I.H. Stress-induced activation of the HPA axis predicts connectivity between subgenual cingulate and salience network during rest in adolescents. J. Child Psychol. Psychiatry 2011, 52(10):1026-1034.
90. Toffanin T., et al. Volumetric MRI analysis of hippocampal subregions in Cushing's disease: a model for glucocorticoid neural modulation. Eur. Psychiatry 2011, 26(1):64-67.
91. Vaisvaser S., et al. Neural traces of stress: cortisol related sustained enhancement of amygdala-hippocampal functional connectivity. Front. Hum. Neurosci. 2013, 7:313.
92. van Berckel B.N., et al. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology (Berl) 1998, 137(3):271-281.
93. van Osch M.J., et al. Can arterial spin labeling detect white matter perfusion signal?. Magn. Reson. Med. 2009, 62(1):165-173.
94. Veer I.M., et al. Endogenous cortisol is associated with functional connectivity between the amygdala and medial prefrontal cortex. Psychoneuroendocrinology 2012, 37(7):1039-1047.
95. Vollenweider F.X., et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur. Neuropsychopharmacol. 1997, 7(1):9-24.
96. Vreeburg S.A., et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch. Gen. Psychiatry 2009, 66(6):617-626.
97. Vythilingam M., et al. Smaller head of the hippocampus in Gulf War-related posttraumatic stress disorder. Psychiatry Res. 2005, 139(2):89-99.
98. Wang J., et al. Perfusion functional MRI reveals cerebral blood flow pattern under psychological stress. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(49):17804-17809.
99. Xie G., et al. Critical involvement of the thalamus and precuneus during restoration of consciousness with physostigmine in humans during propofol anaesthesia: a positron emission tomography study. Br. J. Anaesth. 2011, 106(4):548-557.
100. Yan C.G., et al. A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics. NeuroImage 2013, 76:183-201.
101. Zarate C., et al. New paradigms for treatment-resistant depression. Ann. N. Y. Acad. Sci. 2013, 1292:21-31.
102. Zarate C.A., Mathews D.C., Furey M.L. Human biomarkers of rapid antidepressant effects. Biol. Psychiatry 2013, 73(12):1142-1155.
103. Zarei M., et al. Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer's disease. NeuroImage 2013, 66:28-35.
104. Zeger S.L., Liang K.Y., Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988, 44(4):1049-1060.